J. Biol. Chem., Vol. 266, Issue 13, 8143-8148, 05, 1991

Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371)

JD Page and RW Colman
Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

The predominant autolytic form of human kallikrein, beta-kallikrein, was used to localize the high molecular weight kininogen (HK) binding site on kallikrein as well as the substrate recognition site for activated factor XII on prekallikrein. beta-Kallikrein is formed by autolysis of the kallikrein heavy chain to give two fragments of approximately 18 and 28 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A ligand binding technique established that the HK binding site on kallikrein residues on the 28-kDa fragment of the heavy chain. Limited NH2-terminal sequencing of this portion of beta- kallikrein showed that this fragment of the heavy chain consists of the COOH-terminal 231 amino acids of the heavy chain. A panel of five murine monoclonal antibodies to human prekallikrein (PK) were found to have epitopes on this same fragment of the heavy chain. None of the monoclonal antibodies were able to block binding of HK to PK. Three of the monoclonal antibodies (13G11, 13H11, and 6A6) were able to inhibit the activation of PK to kallikrein in both a plasma system and a purified system. The 28-kDa fragment of the PK heavy chain was purified and was able to compete with HK for binding to PK. The HK binding site and the site of recognition of factor XII are separate and distinct on PK, and both are contained in the COOH-terminal 231 amino acids of the PK heavy chain.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Renne, J. Dedio, J. C. M. Meijers, D. Chung, and W. Muller-Esterl Mapping of the Discontinuous H-kininogen Binding Site of Plasma Prekallikrein. EVIDENCE FOR A CRITICAL ROLE OF APPLE DOMAIN-2 J. Biol. Chem., September 3, 1999; 274(36): 25777 - 25784. [Abstract] [Full Text] [PDF]

				R. W. Colman and A. H. Schmaier Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes Blood, November 15, 1997; 90(10): 3819 - 3843. [Full Text] [PDF]

				Y. Lin, R. B. Harris, W. Yan, K. R. McCrae, H. Zhang, and R. W. Colman High Molecular Weight Kininogen Peptides Inhibit the Formation of Kallikrein on Endothelial Cell Surfaces and Subsequent Urokinase-Dependent Plasmin Formation Blood, July 15, 1997; 90(2): 690 - 697. [Abstract] [Full Text] [PDF]

				H. Herwald, T. Renne, J. C. M. Meijers, D. W. Chung, J. D. Page, R. W. Colman, and W. Muller-Esterl Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein. A DISTAL BINDING SEGMENT IS LOCATED IN THE HEAVY CHAIN DOMAIN A4 J. Biol. Chem., May 31, 1996; 271(22): 13061 - 13067. [Abstract] [Full Text] [PDF]

				F. A. Baglia and P. N. Walsh A Binding Site for Thrombin in the Apple 1 Domain of Factor XI J. Biol. Chem., February 16, 1996; 271(7): 3652 - 3658. [Abstract] [Full Text] [PDF]